# Nanotechnology as a Key to Enhance the Benefits and Improve the Bioavailability of Flavonoids in the Food Industry

**Authors:** Jocelyn C. Ayala-Fuentes, Rocio Alejandra Chavez-Santoscoy

PMC · DOI: 10.3390/foods10112701 · Foods · 2021-11-05

## TL;DR

This paper reviews how nanotechnology can improve the stability and bioavailability of flavonoids in food and health products.

## Contribution

The paper provides a comprehensive review of recent nanoencapsulation techniques for flavonoids and compares natural and synthetic biopolymers.

## Key findings

- Nanoencapsulation enhances the stability and bioavailability of flavonoids.
- Natural and biocompatible biopolymers are preferred for nanoencapsulation.
- Nanocapsules improve targeted delivery of flavonoids in the body.

## Abstract

Nanotechnology has impacted the food industry, mainly on developing healthier, safer, and high-quality functional food. Flavonoids are valuable compounds present in plants, fruits, grains, roots, stems, tea, and wine, among others; they possess many benefits for health due to their antioxidant properties toward reactive oxygen species, anti-inflammatory, and antiproliferative, among others. These characteristics make flavonoids attractive in various industrial areas such as medicine, nutraceutical, cosmetology, and pharmaceutical. Unfortunately, flavonoids lack long-term stability, are sensitive to light, long periods of darkness with low oxygen concentration, and often present a low water solubility and poor bioavailability. Nanoencapsulation is an alternative to improve bioavailability and sensitivity in the manufacturing process, based on encapsulating substances on a nanoscale. Nanocapsules are a promising strategy in significantly enhancing the delivery of compounds to various sites in the body. The development of biopolymers to encapsulate sensitive compounds is increasing, as well as the search for the non-toxic, biodegradable, natural and biocompatible characteristics of polymers, is fundamental. The present review describes the recent techniques and technologies for the nanoencapsulation of flavonoids. It discusses their potential advantages and possible limitations, compares natural and synthetic biopolymers, and finally, details nanoparticle regulation.

## Full-text entities

- **Diseases:** autoimmune illness (MESH:D001327), urinary tract infection (MESH:D014552), inflammatory (MESH:D007249), cancer (MESH:D009369), COVID-19 (MESH:D000086382), metabolic, neurodegenerative diseases (MESH:D019636), host disease (MESH:D004194), chronic disorders (MESH:D002908), blood coagulation (MESH:D001778), cardiovascular disorders (MESH:D002318), cytotoxicity (MESH:D064420), Alzheimer (MESH:D000544)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Powellomyces sp. EA (species) [taxon 252690], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8621120/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8621120/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC8621120/full.md

---
Source: https://tomesphere.com/paper/PMC8621120